Search research articles
Contact Us
Filters
Showing results (291-300 of 319) with videos related to
Page
of 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2010
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
Bianca A W Hoeben, Johannes H A M Kaanders, Gerben M Franssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer
Ernst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Plos One
|
February 14, 2015
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients
Sandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts
Rafke Schoffelen, Robert M Sharkey, David M Goldenberg, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2010
Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
Leo A B Joosten, Frank L Van De Veerdonk, Alieke G Vonk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 28, 2016
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses
Tim J A Hutten, Soley Thordardottir, Hanny Fredrix, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2014
mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines
Theo S Plantinga, Bas Heinhuis, Danny Gerrits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2013
The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas
Emmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Sandra Heskamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma
Adrienne H Brouwers, Peter F A Mulders, Pieter H M de Mulder, et al.
Molecular Imaging and Biology
|
November 1, 2016
Response Monitoring with [<sup>18</sup>F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases
Sandra Heskamp, Linda Heijmen, Danny Gerrits, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 319) with videos related to
Sort By:
Page
of 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2010
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
Bianca A W Hoeben, Johannes H A M Kaanders, Gerben M Franssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer
Ernst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Plos One
|
February 14, 2015
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients
Sandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts
Rafke Schoffelen, Robert M Sharkey, David M Goldenberg, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2010
Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
Leo A B Joosten, Frank L Van De Veerdonk, Alieke G Vonk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 28, 2016
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses
Tim J A Hutten, Soley Thordardottir, Hanny Fredrix, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2014
mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines
Theo S Plantinga, Bas Heinhuis, Danny Gerrits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2013
The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas
Emmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Sandra Heskamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma
Adrienne H Brouwers, Peter F A Mulders, Pieter H M de Mulder, et al.
Molecular Imaging and Biology
|
November 1, 2016
Response Monitoring with [<sup>18</sup>F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases
Sandra Heskamp, Linda Heijmen, Danny Gerrits, et al.
Page
of 32